NCT01639807View on ClinicalTrials.gov

Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP

NAUnknownINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2014

Conditions

Glaucoma

Interventions

DRUG

Latanoprost

Latanoprost (0.005%) eye drops, once daily in the evening

PROCEDURE

SLT

Selective Laser Trabeculoplasty

Trial Locations (1)

625 020

RECRUITING

Aravind Eye Hospital, Madurai

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Aurolab

OTHER

NCT01639807 - Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP | Biotech Hunter | Biotech Hunter